30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

SQZ Biotechnologies Co (SQZ)

Track

Stock chart
Ticker: SQZ Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Capasso Richard
See Remarks
1 sale — total 3,935 USD
Sale 15 Aug 2022
Value US$2,796,330.30 | Price 498.35 | Shares 58,977
Buy 25 May 2022
Value US$2,458,954.31 | Price 239.04 | Shares 96,032
Buy 13 Dec 2021
Value US$20,239.00 | Price 10.94 | Shares 1,850
Buy 13 Dec 2021
Value US$20,128.00 | Price 10.88 | Shares 1,850
Buy 3 Nov 2020
Value US$10,000,000.00 | Price 16.00 | Shares 625,000
Buy 3 Nov 2020
Value US$3,738,464.00 | Price 16.00 | Shares 233,654
Buy 3 Nov 2020
Value US$261,536.00 | Price 16.00 | Shares 16,346
Buy 3 Nov 2020
Value US$3,738,464.00 | Price 16.00 | Shares 233,654
Buy 3 Nov 2020
Value US$261,536.00 | Price 16.00 | Shares 16,346
Buy 3 Nov 2020
Value US$7,440,000.00 | Price 16.00 | Shares 465,000
Buy 30 Oct 2020
Value US$10,000,000.00 | Price 16.00 | Shares 625,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-16 2022-08-15 S Sale
3.2
Capasso Richard

See Remarks

Officer
58,977 +6.2%
498.35
US$2,796,330 		58,977 +6.2% 498.35 US$2,796,330
2022-05-27 2022-05-25 B Purchase
1.3
Jensen Klavs F.
Non-Executive Director
96,032 -42.9%
239.04
US$2,458,954 		96,032 -42.9% 239.04 US$2,458,954
2021-12-15 2021-12-13 B Purchase
2.6
SCHULMAN AMY W
Non-Executive Director Large shareholder
59,576 -45.8%
83.51
US$3,273,551 		59,576 -45.8% 83.51 US$3,273,551
2021-12-15 2021-12-13 B Purchase
2.6
SCHULMAN AMY W
Non-Executive Director Large shareholder
1,850 +inf%
10.88
US$20,128 		1,850 +inf% 10.88 US$20,128
2020-11-05 2020-11-03 B Purchase
3.2
Temasek Holdings (Private) Ltd
Large shareholder
625,000 +33.1%
16.00
US$10,000,000 		625,000 +33.1% 16.00 US$10,000,000
2020-11-03 2020-11-03 B Purchase
2.6
SCHULMAN AMY W
Non-Executive Director Large shareholder
233,654 +10.1%
16.00
US$3,738,464 		233,654 +10.1% 16.00 US$3,738,464
2020-11-03 2020-11-03 B Purchase
2.6
SCHULMAN AMY W
Non-Executive Director Large shareholder
16,346 +10.1%
16.00
US$261,536 		16,346 +10.1% 16.00 US$261,536
2020-11-03 2020-11-03 B Purchase
1.9
Polaris Management Co. VII, L.L.C.
Large shareholder
233,654 +10.1%
16.00
US$3,738,464 		233,654 +10.1% 16.00 US$3,738,464
2020-11-03 2020-11-03 B Purchase
1.9
Polaris Management Co. VII, L.L.C.
Large shareholder
16,346 +10.1%
16.00
US$261,536 		16,346 +10.1% 16.00 US$261,536
2020-11-03 2020-11-03 B Purchase
3.8
Invus Public Equities, L.P.
Large shareholder
465,000 +40.7%
16.00
US$7,440,000 		465,000 +40.7% 16.00 US$7,440,000
2020-11-02 2020-10-30 B Purchase
2.9
AMERICAN INTERNATIONAL GROUP INC
Large shareholder
625,000 +inf%
16.00
US$10,000,000 		625,000 +inf% 16.00 US$10,000,000
Explore more

More insider trading research around SQZ Biotechnologies Co

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America